Literature DB >> 1369164

Fragmented DNA and apoptotic bodies document the programmed way of cell death in hybridoma cultures.

F Franĕk1, T Vomastek, J Dolníková.   

Abstract

Markers of apoptosis were followed in batch hybridoma cultures carried out in protein-free medium. Samples were collected on day 0, representing early exponential phase (viability 91%), and on day 8, corresponding to late stationary phase (viability 8%). The apoptotic index reflecting the relative number of bodies insoluble in 6 M guanidinium hydrochloride in the culture of day 8 (30%) exceeded markedly the index in the culture of day 0 (2.5%). A gel chromatography on Sepharose 2B was developed for quantitative evaluation of fragmented cellular DNA. This analysis, including a correction for nonspecific fragmentation, showed that on day 8 more than 30% of cellular DNA was fragmented, whereas on day 0 it was less than 5%. Control necrotic cells prepared by rapid killing in 1% sodium azide displayed a low apoptotic index (2.4%) and low DNA fragmentation. Electrophoretic patterns in agarose gel showed a typical "ladder" of fragments in the DNA sample of day 8. The demonstration of fragmented cellular DNA and of the high incidence of apoptotic bodies at late stationary phase adds substantial weight to the view that in hybridoma cultures apoptosis represents the prevalent mode of cell death.

Entities:  

Mesh:

Year:  1992        PMID: 1369164     DOI: 10.1007/bf02521738

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  12 in total

1.  Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration.

Authors:  F Franĕk; J Dolníková
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

2.  Electron microscopy of hybridoma cells with special regard to monoclonal antibody production.

Authors:  M al-Rubeai; D Mills; A N Emery
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

3.  Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation.

Authors:  Y F Shi; M G Szalay; L Paskar; B M Sahai; M Boyer; B Singh; D R Green
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

4.  The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).

Authors:  M Piacentini; L Fesus; M G Farrace; L Ghibelli; L Piredda; G Melino
Journal:  Eur J Cell Biol       Date:  1991-04       Impact factor: 4.492

Review 5.  Apoptosis: molecular mechanisms in programmed cell death.

Authors:  L Fesus; P J Davies; M Piacentini
Journal:  Eur J Cell Biol       Date:  1991-12       Impact factor: 4.492

6.  Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action.

Authors:  L Fesus; V Thomazy; F Autuori; M P Ceru; E Tarcsa; M Piacentini
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

7.  Induction and activation of tissue transglutaminase during programmed cell death.

Authors:  L Fesus; V Thomazy; A Falus
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

8.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

9.  Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen.

Authors:  M K Newell; L J Haughn; C R Maroun; M H Julius
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

10.  On-line monitoring of monoclonal antibody formation in high density perfusion culture using FIA.

Authors:  C Fenge; E Fraune; R Freitag; T Scheper; K Schügerl
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

View more
  17 in total

1.  A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of 'leaky' SCID mice.

Authors:  L J Mason; C T Ravirajan; D S Latchman; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Apoptosis in CHO cell batch cultures: examination by flow cytometry.

Authors:  A Moore; C J Donahue; J Hooley; D L Stocks; K D Bauer; J P Mather
Journal:  Cytotechnology       Date:  1995-02       Impact factor: 2.058

3.  Cell suicide in starving hybridoma culture: survival-signal effect of some amino acids.

Authors:  F Franěk; K Srámková
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

4.  Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues.

Authors:  A Moore; J Mercer; G Dutina; C J Donahue; K D Bauer; J P Mather; T Etcheverry; T Ryll
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

5.  Cell suicide in starving hybridoma culture: survival-signal effect of some amino acids.

Authors:  F Franěk; K Srámková
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

6.  Apoptosis and nutrition: Involvement of amino acid transport system in repression of hybridoma cell death.

Authors:  F Franěk; K Chládková-Šrámková
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

7.  Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture.

Authors:  F Franek; M Strnad; L Havlícek; V Siglerová; I Fismolová; T Eckschlager
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

8.  Induction of apoptosis in oxygen-deprived cultures of hybridoma cells.

Authors:  S Mercille; B Massie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 9.  Modeling of cell culture processes.

Authors:  E Tziampazis; A Sambanis
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

10.  Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas.

Authors:  J Perreault; R Lemieux
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.